Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

5.10
+0.680015.38%
Post-market: 5.100.00000.00%19:30 EDT
Volume:111.49K
Turnover:535.48K
Market Cap:189.63M
PE:-0.97
High:5.10
Open:4.42
Low:4.42
Close:4.42
52wk High:16.34
52wk Low:2.40
Shares:37.18M
Float Shares:11.88M
Volume Ratio:1.06
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2744
EPS(LYR):-4.8000
ROE:-3439.35%
ROA:-25.83%
PB:-0.82
PE(LYR):-1.06

Loading ...

Company Profile

Company Name:
Armata Pharmaceuticals, Inc.
Exchange:
AMEX
Establishment Date:
- -
Employees:
61
Office Location:
5005 McConnell Avenue,Los Angeles,California,United States
Zip Code:
90066
Fax:
310 665 2963
Introduction:
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Directors

Name
Position
Deborah L. Birx
Chief Executive Officer and Director
Robin C. Kramer
Chair of the Board and Director
Daniel B. Gilmer
Director
Joseph M. Patti
Director
Jules Haimovitz
Director
Odysseas D. Kostas
Director
Sarah J. Schlesinger
Director

Shareholders

Name
Position
Deborah L. Birx
Chief Executive Officer and Director
David D. House
Principal Financial Officer and Senior Vice President, Finance
Pierre Kyme
Chief Business Officer